Abstract
Mycophenolate mofetil resulted in rapid improvement of steroid-refractory immune-related adverse event hepatitis, induced by nivolumab plus ipilimumab.
Author supplied keywords
Cite
CITATION STYLE
APA
Omori, G., Takada, K., Murase, K., Hayasaka, N., Nakamura, H., Iyama, S., … Kato, J. (2021). Successful mycophenolate mofetil treatment of a patient with severe steroid-refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer. Clinical Case Reports, 9(2), 654–659. https://doi.org/10.1002/ccr3.3597
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free